Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit
June 25 2019 - 4:05PM
Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage
biotechnology company developing innovative therapeutics targeting
hepatitis B virus (HBV) and diseases associated with the
microbiome, today announced participation in the Microbiome
Movement Drug Development Summit, to be held June 26-28, 2019 in
Boston.
Assembly will participate in the following presentation and
panels at the Summit:
Presentation: Discovery and Development of
Rationally-Selected Consortia of Live Microbial Biotherapeutics
Based on Disease Relevant MechanismsPresenter:
Jackie Papkoff, PhD, Senior Vice President, Chief Scientific
Officer Microbiome Date/Time: Thursday, June 27,
2019 at 3:10pm ET
Panel: Manufacturing and Scaling Live
Biotherapeutic Products (LBP)Panelist: Wayne
Herber, PhD, Senior Vice President Biological
ManufacturingDate/Time: Thursday, June 27, 2019 at
12pm ET
Panel: New Perspectives on Pharmaceutical &
Biotech Partnerships in the MicrobiomePanelist:
Micah Mackison, Senior Vice President Corporate Development &
StrategyDate/Time: Friday, June 28, 2019 at
12:30pm ET
About Assembly BiosciencesAssembly
Biosciences, Inc. is a clinical-stage biotechnology company
developing innovative therapeutics targeting hepatitis B virus
(HBV) and diseases associated with the microbiome. The HBV program
is focused on advancing a new class of potent, oral core inhibitors
that have the potential to increase cure rates for chronically
infected patients. The microbiome program is developing novel
oral live microbial biotherapeutic candidates with Assembly’s fully
integrated platform, including a robust process for strain
identification and selection, GMP banking and production, and
targeted delivery to the lower gastrointestinal tract with the
GEMICEL® technology. For more information,
visit assemblybio.com.
Contacts Assembly Biosciences, Inc. Investors:
Lauren Glaser (415) 521-3828 lglaser@assemblybio.com
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
From Sep 2023 to Sep 2024